Balinsua, April Rose Y.

HRN: 27-68-00  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/31/2025
CEFTRIAXONE 1G (VIAL)
08/31/2025
09/07/2025
IV
2gms
OD X 7 Days
T/C Endometritis
Checking Initial Appropriateness 
09/01/2025
AMPICILLIN 1GM (VIAL)
09/01/2025
09/08/2025
IV
2g
Q6h
T/C Endometritis
Checking Initial Appropriateness 
09/04/2025
METRONIDAZOLE 500MG (TAB)
09/04/2025
09/11/2025
PO
1 Tab
TID
S/P D&C
Checking Initial Appropriateness 
09/04/2025
CO-AMOXICLAV 625MG (TAB)
09/04/2025
09/11/2025
PO
1 Tab
TID
S/P CS
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: